INPLASY2020120070

Efficacy and Safety of PD-(L)1 inhibitors plus Chemotherapy versus Chemotherapy in Treatment for Triple Negative Breast Cancer：A meta-Analysis of Randomized Control Trials

Keywords: PD-1/PD-L1; atezolizumab; pembrolizumab; immunotherapy; metastatic triple negative breast cancer; systematic review; meta-analysis.

Download PDF - 2020120070